News & Updates

Individuals who contracted bacterial meningitis as children appear to be at greater risk of having long-term disabilities, as reported in a study from Sweden.

Adding bevacizumab (B) to temozolomide (T)-based chemotherapy increases overall response rate (ORR) in children with relapsed/refractory (R/R) neuroblastoma, according to results of the three-by-two factorial, randomized controlled phase II BEACON-Neuroblastoma trial.

Expectant mothers who use the antiseizure medication levetiracetam as monotherapy do not appear to have increased overall risk of major birth defects or miscarriage, as reported in a study.

Treatment with ganaxolone in paediatric patients with cyclin-dependent kinase-like 5 deficiency disorder (CDD) leads to reductions in major motor seizure frequency (MMSF) over 2 years, according to data from the open-label extension phase of the Marigold trial.

Taking cocoa extract (CE) supplements daily appears to be no better than placebo in improving the cognitive function of older adults who underwent repeat in-person, detailed neuropsychological assessments over 2 years, a study has shown.

A recent study has shown that among individuals with chronic hyponatremia, its correction leads to improved cognitive function as well as decreased brain volume and neuronal activity.

Older adults with Alzheimer's disease who are receiving treatment with acetylcholinesterase inhibitors (AChEIs) appears to have a small reduction in the risk of age-related macular degeneration (AMD), as reported in a study.